European Leukemia Trial Registry
Trial: ST AmBisome loading

More Details
Scientific Title A phase 3b, multi-center, randomized, double blind study of the safety and efficacy of an AmBisome loading dose regimen versus a standard AmBisome regimen for the initial treatment of invasive aspergillosis and other filamentous fungal infections in immunocompromised patients
Short Title ST AmBisome loading
Trialgroup NN
Disease Miscellaneous(Miscellaneous) Supportive Care
Age All ages
Status Closed
Start of Recruitment 01.01.2006
Leader Cornely, Prof. Dr., Oliver A.
Centre of Trial Universitätsklinikum der Universität zu Köln
Shortprotocol Shortprotocol
created 21.09.2006 Deniz Gökbuget
changed 10.07.2013 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org